-+ 0.00%
-+ 0.00%
-+ 0.00%

TG THERAPEUTICS ANNOUNCES PHASE 1 DATA EVALUATING AZER-CEL IN PROGRESSIVE MULTIPLE SCLEROSIS IN A LATE-BREAKING ORAL PRESENTATION AT MSTORONTO2026

Reuters·10/23/2026 14:55:00

Please log in to view news